Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Arsani Insider Profile
4 Followers
William Arsani, Director at Design Therapeutics, holds 4.22M shares in Design Therapeutics (Ticker: DSGN). Most recently, William Arsani Sold $814,874 shares of Design Therapeutics on Aug 12, 2024 for an estimated value of 3.46M.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-6.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that William Arsani holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 30, 2023 - Aug 30, 2024
Return:+83.10%
The most profitable trade made by William Arsani
William Arsani's Trading History
List of latest transactions for each holding click on a transaction to see William Arsani's performance on stock
You May Also Like
William Arsani insider profile FAQ
What is the percentage of profitable transactions made by William Arsani?
The percentage of profitable transactions made by William Arsani is 40%.
What is the average return per transaction made by William Arsani?
The average return per transaction made by William Arsani is -6.90%.
What stocks does William Arsani hold?
William Arsani holds: DSGN stocks.
What was William Arsani’s latest transaction?
William Arsani latest transaction was an Informative Sell of $3.46M.
What was William Arsani's most profitable transaction?
William Arsani’s most profitable transaction was an Informative Buy of DSGN stock on August 30, 2023. The return on the trade was 83.10%.
What is William Arsani's role in Design Therapeutics?
William Arsani's role in Design Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.